A detailed history of Pictet Asset Management Holding Sa transactions in Exelixis, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 925,857 shares of EXEL stock, worth $24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
925,857
Previous 2,053,333 54.91%
Holding current value
$24 Million
Previous $48.7 Million 57.3%
% of portfolio
0.02%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $22.9 Million - $26.8 Million
-1,127,476 Reduced 54.91%
925,857 $20.8 Million
Q1 2024

May 14, 2024

SELL
$20.17 - $23.93 $3.46 Million - $4.11 Million
-171,576 Reduced 7.71%
2,053,333 $48.7 Million
Q4 2023

Feb 13, 2024

BUY
$19.25 - $24.13 $5.44 Million - $6.81 Million
282,421 Added 14.54%
2,224,909 $53.4 Million
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $37 Million - $44.2 Million
1,942,488 New
1,942,488 $42.4 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $8.35B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.